SCHEMBL1090409

SCHEMBL1090409

COc1ccc(S(=O)(=O)N2CCCC(N3CCC(Nc4nccc(N5CCCCCC5)n4)C3)C2)cc1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.45
ALDH1A1 P00352 5/20 0.45
KDM4E B2RXH2 3/20 0.45
GAA P10253 2/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C19 P33261 1/20 0.45
CXCR4 P61073 1/20 0.45
HTT P42858 2/20 0.43
HRH4 Q9H3N8 1/20 0.43
CCR6 P51684 3/20 0.42
IKBKB O14920 1/20 0.42
CCNC P24863 1/20 0.41
CDK8 P49336 1/20 0.41
ADRB2 P07550 1/20 0.41
RAB9A P51151 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1090887 0.97 TSHR (0.47) TSHRALDH1A1KDM4EGAACYP2D6
SCHEMBL1089079 0.96 TSHR (0.49) TSHRALDH1A1KDM4EGAACYP2D6
SCHEMBL1091267 0.92 ALDH1A1 (0.56) ALDH1A1KDM4EGAACYP2D6CYP2C19
SCHEMBL1089055 0.91 CXCR4 (0.47) ALDH1A1KDM4ECXCR4HRH4IKBKB
SCHEMBL1090651 0.91 TSHR (0.48) TSHRGAACXCR4HRH4IKBKB
SCHEMBL1089652 0.90 MEN1 (0.45) CXCR4HTTHRH4IKBKBCCNC
SCHEMBL1091184 0.89 ALDH1A1 (0.57) TSHRALDH1A1KDM4EGAACYP2D6
SCHEMBL1089328 0.89 CXCR4 (0.55) ALDH1A1KDM4EGAACXCR4HRH4
SCHEMBL1090003 0.89 CXCR4 (0.45) ALDH1A1GAACXCR4HRH4CCR6
SCHEMBL1090746 0.88 ALDH1A1 (0.57) TSHRALDH1A1KDM4EGAACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 TSHR 3693/4885ALDH1A1 916/4885KDM4E 2001/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 TSHR 3693/4885ALDH1A1 916/4885KDM4E 2001/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 TSHR 3693/4885ALDH1A1 916/4885KDM4E 2001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.